The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Investigating clinical and molecular characteristics of patients with PIK3CA mutation with and without KRAS mutations in colorectal cancer.
 
Ashley McFarquhar
No Relationships to Disclose
 
Shuaichao Wang
No Relationships to Disclose
 
Paola Zinser
No Relationships to Disclose
 
Bhaghyasree Jambunathan
No Relationships to Disclose
 
Doga Kahramangil
No Relationships to Disclose
 
Aatur Singhi
Honoraria - Foundation Medicine
 
Anwaar Saeed
Consulting or Advisory Role - Arcus therapeutics; Astellas Pharma; AstraZeneca; Autem Therapeutics; Autem therapeutics; BeOne therapeutics; Bristol-Myers Squibb; Exelixis; Pfizer; Regeneron; Replimune; Taiho Pharmaceutical; Xilio therapeutics
Research Funding - Actuate Therapeutics (Inst); Arcus therapeutics (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); BeOne therapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Incyte (Inst); KAHR Medical (Inst); Merck Sharp & Dohme (Inst); Oxford biotherapeutics (Inst); Phanes Therapeutics (Inst); Replimune (Inst)
 
Ibrahim Sahin
Consulting or Advisory Role - GlaxoSmithKline; Guardant Health; Seagen
Speakers' Bureau - Amgen; Pfizer